Doctors just found a way to slow one of the deadliest prostate cancers
A major international study led by UCL researchers has found that combining two cancer drugs could substantially slow the progression of a severe and often deadly form of prostate cancer in men with specific genetic mutations. Published in Nature Medicine, the Phase III AMPLITUDE trial tested whether adding niraparib, a…
